What are the benefits and challenges of making the Ervebo vaccine available to the public during the Ebola outbreak in DR Congo?
WHO vaccine experts on Friday recommended a full-scale human trial of the only existing approved Ebola vaccine to see if it offers cross-protection against a deadly strain spreading in the DR Congo
Source Articles
France24 (France) | Aug 10, 2026
France24 (France) | Aug 10, 2026
France24 (France) | Aug 11, 2026
Science Magazine (United States) | Aug 11, 2026
STAT News (United States) | Aug 12, 2026
The Conversation (United Kingdom) | Aug 14, 2026
Your votes count
No account needed. Your votes are saved and included in the consensus analysis. Create an account to keep a record of your votes.
💡 How this works
- • Add statements: Post claims or questions (10 to 500 characters).
- • Vote: Agree, disagree or unsure on each statement.
- • Respond: Add detailed arguments for or against, with evidence.
- • Consensus: Once enough people take part, analysis shows opinion groups and where they agree.
Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.
Support us